deltatrials
Completed PHASE2 INTERVENTIONAL 5-arm NCT00548249

Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis

A Dose Ranging Study of Dialysate Containing Soluble Ferric Pyrophosphate (SFP) Versus Control in Subjects With ESRD Receiving Chronic Hemodialysis.

Sponsor: Rockwell Medical Technologies, Inc.

Updated 10 times since 2017 Last updated: Nov 17, 2020 Started: Aug 31, 2007 Primary completion: Oct 31, 2009 Completion: Jan 31, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00548249, this PHASE2 trial focuses on End-Stage Renal Disease (ESRD) and remains completed. Sponsored by Rockwell Medical Technologies, Inc., it has been updated 10 times since 2007, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshotCompleted~Aug 2017 – ~May 2018 · 9 months · monthly snapshotCompleted~May 2018 – ~Jun 2018 · 31 days · monthly snapshotCompleted~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshotCompleted~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

10 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE2

  5. Nov 2020 — Jan 2021 [monthly]

    Completed PHASE2

Show 5 earlier versions
  1. Jun 2018 — Nov 2020 [monthly]

    Completed PHASE2

  2. May 2018 — Jun 2018 [monthly]

    Completed PHASE2

  3. Aug 2017 — May 2018 [monthly]

    Completed PHASE2

  4. Feb 2017 — Aug 2017 [monthly]

    Completed PHASE2

  5. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Rockwell Medical Technologies, Inc.
Data source: Rockwell Medical Technologies, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .